Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Cardiovascular Benefits of Empagliflozin Are Associated With Gut Microbiota and Plasma Metabolites in Type 2 Diabetes
PaperCitations, authors & open-access status
Cardiovascular Benefits of Empagliflozin Are Associated With Gut Microbiota and Plasma Metabolites in Type 2 Diabetes is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 116 citations, 2022 year and hybrid oa status.
116
Citations
2022
Year
hybrid
OA Status